First, the market momentum for Mirum's rare liver disease drug Livmarli should continue. Sales increased 56% year-over-year ...

The third no-brainer stock that can be confidently bought with $1,000 right now for the new year is America's largest ...

These funds are highly rated. Here's what they offer Aussie investors. The post Where I would invest $5,000 in ASX ETFs in ...

These five are great starting points for nearly surefire bets for 2026.

Are you looking for some dividend-growth stocks to add to your portfolio? Here are two great picks that every investor should consider owning. The post 2 Dividend-Growth Stocks to Buy and Hold Through ...

The "Magnificent Seven" was constantly in the spotlight last year, but many of the stocks ultimately failed to outperform the ...

This TSX stock has a steady dividend payment history, offers monthly distributions, and has a high and sustainable yield. The ...

An S&P 500 ETF tracks the S&P 500 ( ^GSPC +0.08%), but the Vanguard S&P 500 Growth ETF ( VOOG +0.35%) takes it a step further ...

Still, much of the market, including Wall Street analysts, sees room to run in the AI sector. Here's one AI company to buy ...